Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Remdesivir Approved by FDA Experimental Antiviral Oct/15/2020 Oct/24/2020 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Sep/23/2020 Oct/19/2020 0
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Sep/22/2020 Oct/15/2020 0
Imatinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/21/2020 Oct/17/2020 0
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/18/2020 Oct/10/2020 0
Tipiracil  Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/17/2020 Oct/16/2020 0
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Sep/14/2020 Oct/05/2020 0
Cobicistat Potential treatment - clinical evidence Used to treat other disease Other treatment Aug/27/2020 Sep/28/2020 0
Sofosbuvir Potential treatment - clinical evidence Used to treat other disease Antiviral Aug/19/2020 Sep/02/2020 0
Nelfinavir mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/05/2020 Sep/03/2020 0